These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Brain catecholamine participation in etimizol activation of the hypophyseal-adrenal cortex system].
    Author: Sapronov NS.
    Journal: Farmakol Toksikol; 1979; 42(3):216-21. PubMed ID: 446699.
    Abstract:
    In the experiments on rats the influence of aethimizol on the blood plasma 11-corticosteroids level and the brain catecholamines content was studied. It is established that an hour after the aethimizol injection (10 mg/kg) the blood corticosteroids concentration increases and the hypothalamic norepinephrine and dophamine levels decrease. The pituitary-adrenal system stimulating effect of aethimizol is blocked to a great extent by the intraventricular injection of 6-hydroxydophamine (250 microgram, twice), but is not prevented by the intraperitoneal reserpine treatment (1.5 mg/kg, twice). Aethimizol potentiates the behavioral effects of L-dioxyphenylalanine in mice. It is suggested that the stimulating action of aethimizol on the pituitary-adrenal system may be attributed to its activation of the catecholamines release and their uptake by the hypothalamus.
    [Abstract] [Full Text] [Related] [New Search]